A $10 million gift from the founder of Scottrade has created a unique and innovative new center at the James to fight multiple myeloma, a rare type of blood cancer. The goal “is to put drugs in veins, to give treatment to patients,” said Don Benson, MD, PhD. In this episode, Benson, one of the world’s leading myeloma experts, describes the impact and creation of the Paula and Roger Riney Family Foundation Center for Advanced Research Excellence (Myeloma CARE). The $10 million gift will fund the development of five drugs in development by Benson and his James colleagues designed to treat myeloma. These drugs utilize immunotherapy and targeted (or precision) cancer treatment techniques “that will exploit the Achilles heel of myeloma cells, their vulnerability,” said Benson, the James Myeloma program director. “If one of the [five] projects is lagging, we’ll kill it as soon as we can and focus on what’s working. The goal is new treatments to patients as fast as possible.”